/PRNewswire/ BioNJ announced the winners of its 2022 Company and Pitch Presentation Competition held in conjunction with the organization s 12th Annual.
/PRNewswire/ BioNJ announced the winners of its 2022 Company and Pitch Presentation Competition held in conjunction with the organization s 12th Annual.
LONDON AND DUBLIN, Silence Therapeutics plc (Nasdaq: SLN), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, and Mallinckrodt plc (OTCMKTS:MNKKQ), a global biopharmaceutical company, today announced filing of a clini
Positive SLN360 data to be presented in late breaker at the American College of Cardiology (ACC) Annual Meeting on April 3, 2022 SLN124 phase 1 study in thalassemia now fully enrolled; on-track for
Harnessing a Natural Mechanism to Silence Disease globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.